“THE EFFECTIVENESS, IMMUNOGENICITY, AND SAFETY OF THE Escherichia coli BASED BIVALENT HUMAN PAPILLOMAVIRUS (TYPES 16 AND 18) VACCINE PREVENTING CERVICAL CANCER: A Systematic Review” (2025) JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 11(3), pp. 21–37. doi:10.53366/jimki.v11i3.795.